Comparison of the Efficacy of Holmium Laser Enucleation of the Prostate in Treating Prostate Volumes of <= 80 and >80 mL

Gazel E., Kaya E., Yalcin S., Aybal H. C., Aydogan T. B., TUNÇ L.

UROLOGIA INTERNATIONALIS, vol.102, no.3, pp.306-310, 2019 (SCI-Expanded) identifier identifier identifier

  • Publication Type: Article / Article
  • Volume: 102 Issue: 3
  • Publication Date: 2019
  • Doi Number: 10.1159/000496173
  • Journal Indexes: Science Citation Index Expanded (SCI-EXPANDED), Scopus
  • Page Numbers: pp.306-310
  • Keywords: Holmium laser enucleation of the prostate, Prostate, Benign prostate hyperplasia, Laser, TRANSURETHRAL RESECTION, HYPERPLASIA, TRIAL, HOLEP
  • Gazi University Affiliated: Yes


Introduction: Holmium laser enucleation of the prostate (HoLEP) is becoming the new standard procedure for treating benign prostatic hyperplasia (BPH), a common condition in aging men. Most studies have focused on proving its efficacy in treating large prostates. In this study, we compared its efficacy in treating small (< 80 mL) and large (> 80 mL) prostates. Methods: This prospective study included 119 patients with BPH who underwent HoLEP by the same surgeon between June 2015 and December 2017. They were divided into 2 groups according to their prostate volumes (<= 80 mL: Group 1; > 80 mL: Group 2). Various pre- and postoperative parameters were compared within and between the groups. Results: International Prostate Symptom Score (IPSS), postvoid residual (PVR) volume, and voiding time (VT) significantly decreased, and the peak urinary flow rate (Qmax), average urinary flow rate (Qave), and quality of life (QoL) score significantly increased postoperatively in both groups. The postoperative changes in IPSS, QoL score, Qmax, Qave, VT, PVR volume, and hemoglobin levels were not significantly different between the groups. In addition, no significant difference was observed in postoperative complications between the groups. Conclusions: Our results indicate that HoLEP is an effective procedure for treating both small and large prostates. (C) 2019 S. Karger AG, Basel